FetalGenID: Reliable Gender Determination in Early Pregnancy
Introducing an innovative solution designed to provide accurate and reliable gender determination early in the pregnancy process. FetalGenID utilizes industry-leading fetal electrocardiogram (ECG) technology to deliver non-invasive and highly accurate gender determination starting as early as the 6th week of pregnancy. Revolutionizing prenatal diagnosis and care, FetalGenID advances your prenatal care with groundbreaking capabilities.
Know About Us
Pioneers in Prenatal CareAt FetalGenID, our vision is to redefine prenatal care through innovation and excellence. We strive to lead the way in advancing genetic testing technologies, ensuring the health and well-being of both mothers and babies. With our commitment to precision, accuracy, and personalized care, we envision a future where every family has access to the highest standard of prenatal healthcare. Join us as we pioneer new frontiers in the field, shaping a healthier tomorrow for generations to come.
At FetalGenID, our mission is to empower healthcare professionals and expectant parents with state-of-the-art prenatal genetic testing solutions. We are dedicated to delivering accurate and timely results, enabling informed decision-making and personalized care plans. Through our commitment to excellence, we strive to enhance the health outcomes of families worldwide, ensuring a brighter and healthier future for generations to come.
At FetalGenID, success is measured by the positive impact we make on prenatal care. Through our innovative technology and unwavering commitment to excellence, we strive to improve health outcomes for mothers and babies worldwide. Our dedication to accuracy, reliability, and patient-centered care sets us apart, ensuring that every family we serve receives the highest standard of genetic testing and support. Together, we're shaping the future of prenatal healthcare, one healthy baby at a time.
FetalGenID's journey began with a vision to revolutionize prenatal care. Founded by a team of passionate experts in genetics and healthcare technology, we embarked on a mission to develop advanced solutions for prenatal genetic testing. Since our inception, we've remained committed to innovation, integrity, and improving maternal and fetal health outcomes. With each milestone, we've strengthened our position as a leader in the field, earning the trust of healthcare professionals and expectant parents worldwide. Today, we continue to build on our legacy of excellence, shaping the future of prenatal care with cutting-edge technology and personalized support.
Our Services
Reliable Results from Early StagesWith the ability to determine gender from as early as the 6th week, FetalGenID significantly advances your prenatal care options. This feature is crucial for genetic counseling and disease management processes. Early gender determination allows families to make informed decisions, enables early diagnosis of diseases, and optimizes the management of genetic conditions.
Who We Are
At MKU Healthcare
Innovating Prenatal Care with FetalGenID
At MKU Healthcare we are dedicated to transforming prenatal diagnosis and care with cutting-edge technological solutions. Our flagship product, FetalGenID, is at the forefront of this revolution, providing reliable and non-invasive early gender determination. Founded by experts in medical technology and healthcare innovation, our mission is to enhance prenatal care, reduce risks, and improve outcomes for families worldwide.
- Early Detection
- High Accuracy
- Non-Invasive
- Seamless Integration
- Expert Analysis
- Global Impact
Meet FetalGenID
Learn more about our product, request a demo, or get detailed information about our early gender determination services by contacting us. Discover how FetalGenID can make a difference in your healthcare institution and elevate your prenatal care to the next level.
+90-5068493146
Opening Hours
- Monday – Friday 8.00 – 18.00
- Saturday 9.00 – 17.00
- Sunday 9.00 – 15.00
Doctor Timetable
Professional and Certificated Doctor consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Professional and Certificated Doctor consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore.
View DetailsFrequently Asked Questions
Get Every Single Answers There If You WantFetal ECG (Electrocardiogram) is a technology that records the electrical activity of a fetus's heartbeat within the womb. This technique is used to assess the heart rate and health status of the fetus. Fetal ECG is particularly valuable for gender determination in early stages of pregnancy and for detecting potential cardiac abnormalities.
As pregnancy progresses, fetal ECG provides more detailed information, allowing for comprehensive monitoring of the fetal health condition. Fetal ECG signals typically occur at low frequencies and require sophisticated signal processing techniques, as these signals must pass through the maternal abdominal tissue layers. These techniques are developed to distinguish fetal signals from the mother's own ECG signals.
Fetal ECG is a non-invasive method, making it a safe option for both the mother and the fetus. It offers valuable insights for prenatal care processes such as genetic counseling and disease management, thereby serving as a critical decision-support tool for families and healthcare providers. Products like FetalGenID, developed by MKU Healthcare, utilize this technology to enable early gender determination and aim to improve prenatal diagnostic processes.
FetalGenID is an innovative technology developed by MKU Healthcare that utilizes fetal electrocardiogram (ECG) data to determine the gender of a fetus non-invasively and with high accuracy. This cutting-edge tool can identify fetal gender as early as the 6th week of pregnancy, significantly earlier than many traditional methods. FetalGenID is designed to integrate seamlessly with existing healthcare systems, providing early, crucial insights that can assist in genetic counseling and prenatal care. It enhances the ability of medical professionals to plan and manage prenatal care effectively, making it an invaluable resource for expecting families and healthcare providers alike.
FetalGenID analyzes fetal ECG data using precise and advanced signal processing algorithms, enabling gender determination even in the early weeks. Our product integrates seamlessly with existing healthcare systems, and the data obtained is evaluated by experienced healthcare professionals.
Learn more about our product, request a demo, or get detailed information about our early gender determination services by contacting us. Discover how FetalGenID can make a difference in your healthcare institution and elevate your prenatal care to the next level.
We Are Here For You
Our Team
Meet Our Specialists
Dr.David Shapiro
10 years of experience
Software Developer Mehmet Emin Aydin
10 years of experience
Assoc. Prof. Muhammed Kürşad Uçar
15 years of experience
Dr.David Shapiro
10 years of experience
Dr.David Shapiro
10 years of experienceAbout Us
A company with 13 years of experience in artificial intelligence development.
Advanced AI and Software Expertise
Customer Service and Support
Collaborative R&D Teams
Academic Research and Publications
Ut wisi enim ad minim veniam, quis laore nostrud exerci tation ulm hedi corper turet suscipit lobortis augue duis dolore te feugait nulla facilisi mazim placerat exerci tation ulm hedi corpe.Ut wisi enim ad minim veniam, quis laore nostrud.
Userful Links
Privacy Policy
Reach Us
380 St Kilda Road, Melbourne VIC 3004, Sidney / Australia